ALX Oncology Holdings Inc. (ALXO) Tops Q4 EPS by 12c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Dollar stores see mixed outlook ahead of earnings next week, Gordon Haskett comments
• Ross Stores, Inc. (ROST) PT Raised to $239 at UBS on Q2 Earnings Beat